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Synthesis of celecoxib succinamidic acid (CEL): Briefly, celecoxib (1.0 g, 2.6 mmol), succinic anhydride (1.3 g, 13 mmol) and triethylamine (0.5 mL) were dissolved in dichloromethane (50 mL), and stirred at room temperature for 24 h. After reaction, the solvent was removed under vacuum and the crude product was purified by column chromatography using the mixture of n-hexane and ethyl acetate (3:1) as eluent. The product was characterized by 1 H NMR ( Figure S1 ).
Synthesis of MSNs-SS-CEL: Celecoxib succinamidic acid (0.2 g, 0.4 mmol), EDC (0.1 g, 0.5 mmol) and NHS (0.05 g, 0.4 mmol) were dissolved in anhydrous DMSO (15 mL), and stirred for 4 h at room temperature. Then, the mixture was added into MSNs-SS-NH 2 (0.2 g) suspension in anhydrous DMSO (10 mL), and stirred at room temperature for 24 h. The
MSNs-SS-CEL were collected, washed, dried as above described.
Synthesis of MSNs-SS-Bz: MSNs-SS-NH 2 (0.2 g) were dispersed in anhydrous DMF (30 mL) with DIPEA (0.5 mL), then benzoyl chloride (200 L in 5 mL DMF) was added dropwise to the dispersion in an ice bath and stirred at room temperature for 12 h. The MSNs-SS-Bz were obtained by washing and drying.
Doxorubicin loading and PCD wrapping: The silica nanoparticles (MSNs-SS-CEL and MSNs-SS-Bz, 200 mg) were dispersed in phosphate buffered saline (PBS, pH 7.4, 100 mL), respectively. Subsequently, doxorubicin solution (50 mg, in 10 mL water) was added and the suspension was stirred for 24 h. Then, poly( -cyclodextrin) (PCD, 300 mg) was added and the suspension was stirred for another 24 h. Next, the DOX-loaded nanoparticles were washed (DOX@MSCPs and DOX@MSBPs) with PBS and water, and obtained by lyophilization.
The PCD wrapped MSNs without DOX (MSCPs and MSBPs) were prepared with the same method without DOX loading procedure. The DOX loading contents of DOX@MSCPs and
DOX@MSBPs were determined using a UV-Vis spectrophotometer (Perkin-Elmer Lambda Bio-40 UV/Vis spectrometer) at 480 nm.
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Characterizations of MSNs: The zeta potential and particle size of nanoparticles were determined using Nano-ZS ZEN3600 (Malvern Instruments). Thermal gravimetric analysis (TGA) was conducted on METTLER TOLEDO TGA/DSC 1 actions. N 2 adsorption/desorption isotherm analysis were carried out using an adsorption analyzer (JW-BK112, Beijing JWGB Sci.&Tech. Co.,Ltd.). The morphology and cellular distribution of nanoparticles were observed using transmission electron microscope (TECNAI G2 20 TWIN). 2D 1 H nuclear Overhouser effect spectroscopy (NOESY) spectum was recorded using Bruker Avance III-600 MHz spectrometer (Bruker Biospin, Germany).
Quantitative real-time PCR: Total mRNA in cells or tumor tissues was extracted using
Trizol reagent (Invitrogen, USA) and reversed into cDNA using Hiscript II reverse transcriptase (Vazyme Biotech, China). qPCR was performed on ABI StepOne Plus Detector System (ABI, USA) according to the instructions with AceQ qPCR SYBR® Green Master Mix (Vazyme Biotech, China). Relative expressions of genes were normalized using the house-keeping gene GAPDH as a reference. The primers were presented in Table S1 .
Western blot analysis: Western blot protein analysis was carried out according to our previous study. [2] Briefly, cells or tissues were washed with PBS and lysed by RIPA Lysis
Buffer (Beyotime, China; 50 L, with protease inhibitor). After sonication in the ice bath, the supernatants containing proteins were acquired by centrifugation under 4 o C. Followed by protein measurement by BCA kit, and normalized to uniform concentration, the supernatants were mixed with loading buffer and boiled for 10 min. After electrophoresis in 10% SDS-PAGE gel, the proteins were transferred to NC membranes, followed by primary monoclonal antibody treatment (P-gp, Oct-3/4, Nanog, Notch-3, COX-1, COX-2, GAPDH), then incubated with horseradish peroxidase-coupled secondary antibody. The protein was measured followed by the BeyoECL Plus (Beyotime, China) reagent instructions.
Hemolysis assay: As the previous study, [3] the rabbit red blood cells (RBCs) suspension S5 (2% in PBS, v/v) was mixed with of MSCPs (100 L in PBS), and shaken at 37 o C for 5 h.
Next, the samples were centrifuged to separate the supernatants. The absorbance of supernatants at 545 nm was determined using a UV-Vis spectrophotometer (SHIMADZU UV-1800, Japan).
Biochemical analysis: The tumor-free female BALB/c mice were randomly divided into 4 groups, and treated with PBS, DOX, DOX@MSBPs, or DOX@MSCPs ( 
